Skip to main content
. Author manuscript; available in PMC: 2008 Dec 17.
Published in final edited form as: Vaccine. 2007 Nov 5;25(52):8687–8701. doi: 10.1016/j.vaccine.2007.10.030

Table 3.

Cumulative Summary of Antigen-specific Proliferation and IFN-γ ELISPOT Responses in Monkeys Immunized with Oral Adenoviral DNA-priming and Intranasal Peptide-boosting.

Response to Monkey 53 Monkey 56 Monkey H361
Proliferation (at week) IFN-g ELISPOT (at week) Proliferation (at week) IFN-g ELISPOT (at week) Proliferation (at week) IFN-g ELISPOT (at week)
gp41 peptide- mixture 12, 30, 34 34 19, 34 34 17, 34 34
gp120 peptide- mixture 12, 19, 30, 34 34, 38 34 34 12, 17, 32 30, 34, 38
gp41 + gp120 peptide-mixture 12, 34 34, 38 12, 17 34, 38 17 30, 34, 38
HIV-1 p55 gag protein 12
Heat-inactivated HIV-1 17, 30, 34 38 30, 32, 34 38 17, 22, 30, 32 30, 38
Heat-inactivated Ad5 17, 19 19 17, 19 19
Con A All time points tested All time points tested All time points tested All time points tested All time points tested All time points tested

Note: The weeks shown are for positive responses based on the cutoff values described in the methods section.